Press Releases

    • September 21, 2017

    Nemaura Announces Successful Interim Results for SugarBEAT® European Clinical Trials

    Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    Read more
    August 29, 2017

    Nemaura Develops Medical Grade SugarBEAT® Android App for Diabetes Management

    Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    Read more
    August 15, 2017

    Nemaura Signs Heads of Terms for sugarBEAT® with Device Technologies for Australia and New Zealand

    Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    Read more
    August 9, 2017

    Nemaura Medical Inc. Reports First Quarter 2017 Financial Results

    Nemaura Medical Inc. (OTC: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    Read more
    August 3, 2017

    Nemaura Appoints Thomas Moore to Board of Directors as Independent Director

    Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    Read more
    August 1, 2017

    Nemaura Develops Rechargeable Transmitter for sugarBEAT®

    Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    Read more
    July 26, 2017

    Nemaura Appoints Dr. Salim Natha to Board of Directors as Independent Director, Chair of Compensation Committee

    Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    Read more
    July 20, 2017

    Nemaura Signs Letter of Intent for Licensing Agreement with TPM for GCC Region

    Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    Read more
    July 17, 2017

    Nemaura Appoints Timothy Johnson to Board of Directors as Independent Director, Chairman of Audit and Corporate Governance Committees

    Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    Read more
    July 10, 2017

    Nemaura Medical Inc. announces uplist to OTCQB

    Nemaura Medical Inc. (OTC: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    Read more